C12Y 114/16004
Tryptophan 5-monooxygenase
Official title: Tryptophan 5-monooxygenase (1.14.16.4)
C12Y114/16004 (Tryptophan 5-monooxygenase) appears on 7 US grants and 15 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 15
- Assignees
- 8
- Inventors
- 27
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 3 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 1 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Processes for the production of tryptamines7 Apr 2026US 12,595,497 B2Compass Pathfinder Limited
- Optimized microbial cells for production of melatonin and other compounds9 Jan 2024US 11,866,749 B2Danmarks Tekniske Universitet
- Processes for the production of tryptamines30 May 2023US 11,661,617 B2Compass Pathfinder Limited
- Processes for the production of tryptamines5 Oct 2021US 11,136,293 B2New Atlas Biotechnologies LLC
- Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells13 Jul 2021US 11,060,063 B2The Trustees of Columbia University in the City of New York
- Protein-based material for biocatalysis11 Apr 2024US 2024/0116992 A1Bondwell Technologies LP
- Processes for the production of tryptamines14 Mar 2024US 2024/0084344 A1Compass Pathfinder Limited
- Engineered Microorganisms for Producing Substituted Tryptamines28 Dec 2023US 2023/0416794 A1Algae-C Inc.
- Advanced microbiome therapeutics engineered to produce serotonin in vivo30 Mar 2023US 2023/0098772 A1Danmarks Tekniske Universitet
- Processes for the production of tryptamines9 Sep 2021US 2021/0277433 A1New Atlas Biotechnologies LLC
Most cited
By later US patents
- Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells16US 10,487,314 B2The Trustees of Columbia University in the City of New York · 2019
- Processes for the production of tryptamines10US 11,136,293 B2New Atlas Biotechnologies LLC · 2021
- Optimized microbial cells for production of melatonin and other compounds1US 10,851,365 B2Danmarks Tekniske Universitet · 2020